In breast cancer, miR-125a inhibited cell proliferation and promoted apoptosis by downregulating ELAVL1 which was highly expressed in cancer cells, and this effect was partially rescued by ELAVL1 overexpression (Guo et al., 2009). Here, ELAVL1 is linked to breast cancer.